Format
Sort by
Items per page

Send to

Choose Destination

Search results

Items: 1 to 20 of 57

1.

The psychoactive drug 25B-NBOMe recapitulates rhabdomyolysis in zebrafish larvae.

Kawahara G, Maeda H, Kikura-Hanajiri R, Yoshida KI, Hayashi YK.

Forensic Toxicol. 2017;35(2):369-375. doi: 10.1007/s11419-017-0366-9. Epub 2017 Apr 18.

2.

Changes in the prevalence of new psychoactive substances and their legal status in Japan.

Kikura-Hanajiri R.

Nihon Yakurigaku Zasshi. 2017;150(3):129-134. doi: 10.1254/fpj.150.129. Japanese. No abstract available.

PMID:
28890474
3.

Natural (∆9-THC) and synthetic (JWH-018) cannabinoids induce seizures by acting through the cannabinoid CB1 receptor.

Malyshevskaya O, Aritake K, Kaushik MK, Uchiyama N, Cherasse Y, Kikura-Hanajiri R, Urade Y.

Sci Rep. 2017 Sep 5;7(1):10516. doi: 10.1038/s41598-017-10447-2.

4.

A Metabolic Study on the Biochemical Effects of Chiral Illegal Drugs in Rats Using 1H-NMR Spectroscopy.

Fukuhara K, Ohno A, Kikura-Hanajiri R.

Yakugaku Zasshi. 2017;137(9):1147-1154. doi: 10.1248/yakushi.17-00046.

5.

AB-CHMINACA-induced sudden death from non-cardiogenic pulmonary edema.

Maeda H, Kikura-Hanajiri R, Kawamura M, Nagashima E, Yoshida KI.

Clin Toxicol (Phila). 2017 Jul 14:1-3. doi: 10.1080/15563650.2017.1340648. [Epub ahead of print]

PMID:
28707493
6.
8.

A fatal case of poisoning related to new cathinone designer drugs, 4-methoxy PV8, PV9, and 4-methoxy PV9, and a dissociative agent, diphenidine.

Kudo K, Usumoto Y, Kikura-Hanajiri R, Sameshima N, Tsuji A, Ikeda N.

Leg Med (Tokyo). 2015 Sep;17(5):421-6. doi: 10.1016/j.legalmed.2015.06.005. Epub 2015 Jun 24.

PMID:
26162997
9.

Methylone-induced hyperthermia and lethal toxicity: role of the dopamine and serotonin transporters.

Piao YS, Hall FS, Moriya Y, Ito M, Ohara A, Kikura-Hanajiri R, Goda Y, Lesch KP, Murphy DL, Uhl GR, Sora I.

Behav Pharmacol. 2015 Jun;26(4):345-52. doi: 10.1097/FBP.0000000000000135.

PMID:
25794333
10.

[Evaluation of an on-site drug-testing device for the detection of synthetic cannabinoids in illegal herbal products].

Uchiyama N, Kikura-Hanajiri R, Hakamatsuka T.

Yakugaku Zasshi. 2015;135(3):535-41. doi: 10.1248/yakushi.14-00247. Epub 2015 Jan 19. Japanese.

11.

MAM-2201, a synthetic cannabinoid drug of abuse, suppresses the synaptic input to cerebellar Purkinje cells via activation of presynaptic CB1 receptors.

Irie T, Kikura-Hanajiri R, Usami M, Uchiyama N, Goda Y, Sekino Y.

Neuropharmacology. 2015 Aug;95:479-91. doi: 10.1016/j.neuropharm.2015.02.025. Epub 2015 Mar 5.

PMID:
25747605
12.

UPLC/ESI-MS/MS-based determination of metabolism of several new illicit drugs, ADB-FUBINACA, AB-FUBINACA, AB-PINACA, QUPIC, 5F-QUPIC and α-PVT, by human liver microsome.

Takayama T, Suzuki M, Todoroki K, Inoue K, Min JZ, Kikura-Hanajiri R, Goda Y, Toyo'oka T.

Biomed Chromatogr. 2014 Jun;28(6):831-8. doi: 10.1002/bmc.3155.

PMID:
24861751
13.

Characterization of four new designer drugs, 5-chloro-NNEI, NNEI indazole analog, α-PHPP and α-POP, with 11 newly distributed designer drugs in illegal products.

Uchiyama N, Matsuda S, Kawamura M, Shimokawa Y, Kikura-Hanajiri R, Aritake K, Urade Y, Goda Y.

Forensic Sci Int. 2014 Oct;243:1-13. doi: 10.1016/j.forsciint.2014.03.013. Epub 2014 Mar 27.

PMID:
24769262
14.

Changes in the prevalence of new psychoactive substances before and after the introduction of the generic scheduling of synthetic cannabinoids in Japan.

Kikura-Hanajiri R, Kawamura NU, Goda Y.

Drug Test Anal. 2014 Jul-Aug;6(7-8):832-9. doi: 10.1002/dta.1584. Epub 2013 Dec 26.

PMID:
24573957
15.

Botanical origin of dietary supplements labeled as "Kwao Keur", a folk medicine from Thailand.

Maruyama T, Kawamura M, Kikura-Hanajiri R, Goda Y.

J Nat Med. 2014 Jan;68(1):220-4. doi: 10.1007/s11418-013-0779-7. Epub 2013 May 16.

PMID:
23677774
16.

[Prevalence of new designer drugs and their legal status in Japan].

Kikura-Hanajiri R, Uchiyama N, Kawamura M, Ogata J, Goda Y.

Yakugaku Zasshi. 2013;133(1):31-40. Review. Japanese.

17.

DNA sequence analyses of blended herbal products including synthetic cannabinoids as designer drugs.

Ogata J, Uchiyama N, Kikura-Hanajiri R, Goda Y.

Forensic Sci Int. 2013 Apr 10;227(1-3):33-41. doi: 10.1016/j.forsciint.2012.09.006. Epub 2012 Oct 23.

PMID:
23092848
18.

URB-754: a new class of designer drug and 12 synthetic cannabinoids detected in illegal products.

Uchiyama N, Kawamura M, Kikura-Hanajiri R, Goda Y.

Forensic Sci Int. 2013 Apr 10;227(1-3):21-32. doi: 10.1016/j.forsciint.2012.08.047. Epub 2012 Oct 9.

PMID:
23063179
19.
20.

Methylone and monoamine transporters: correlation with toxicity.

Sogawa C, Sogawa N, Ohyama K, Kikura-Hanajiri R, Goda Y, Sora I, Kitayama S.

Curr Neuropharmacol. 2011 Mar;9(1):58-62. doi: 10.2174/157015911795017425.

Supplemental Content

Loading ...
Support Center